butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate

C275H543N23O22 — CID 160670191

IUPACbutyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate
SMILESCCCCCCCCCN(CCCC(=O)OCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCCCCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCC(=O)OCCCCC)CCC(=O)N1CCN(C(=O)CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCC(OC(=O)CN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCC(=O)OCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCOC(=O)CCCCC)CCC1CCN(C(=O)CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1
InChIInChI=1S/C57H113N5O4.2C56H112N4O3.2C53H103N5O6/c1-6-11-16-20-24-28-32-41-58(45-37-38-57(65)66-54-36-15-10-5)46-39-55(63)61-50-52-62(53-51-61)56(64)40-47-60(44-35-31-27-23-19-14-9-4)49-48-59(42-33-29-25-21-17-12-7-2)43-34-30-26-22-18-13-8-3;1-6-11-16-20-24-28-33-42-57(46-37-52-63-56(62)38-32-15-10-5)47-39-54-40-48-60(49-41-54)55(61)53-59(45-36-31-27-23-19-14-9-4)51-50-58(43-34-29-25-21-17-12-7-2)44-35-30-26-22-18-13-8-3;1-6-11-16-21-26-31-36-43-57(44-37-32-27-22-17-12-7-2)50-51-59(47-40-35-30-25-20-15-10-5)52-55(61)60-48-41-54(42-49-60)63-56(62)53-58(45-38-33-28-23-18-13-8-3)46-39-34-29-24-19-14-9-4;1-6-11-16-19-22-25-28-35-54(38-31-33-52(61)63-46-14-9-4)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(36-29-26-23-20-17-12-7-2)39-32-34-53(62)64-47-15-10-5;1-6-11-16-19-22-25-28-35-54(36-29-26-23-20-17-12-7-2)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(38-31-33-52(61)63-46-14-9-4)39-32-34-53(62)64-47-15-10-5/h6-54H2,1-5H3;2*54H,6-53H2,1-5H3;2*6-49H2,1-5H3
InChIKeyRMVGBSQZDDITBA-UHFFFAOYSA-N
MW4524.51 g/mol
LogP66.20
Rot. Bonds235

About butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate

butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate (PubChem CID 160670191) has the molecular formula C275H543N23O22 and a molecular weight of 4524.51 g/mol. Its IUPAC name is butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate.

Molecular Properties

Compound Namebutyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate
PubChem CID160670191
Molecular FormulaC275H543N23O22
Molecular Weight4524.51 g/mol
Exact Mass4521.21
IUPAC Namebutyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate
SMILESCCCCCCCCCN(CCCC(=O)OCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCCCCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCC(=O)OCCCCC)CCC(=O)N1CCN(C(=O)CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCC(OC(=O)CN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCC(=O)OCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCOC(=O)CCCCC)CCC1CCN(C(=O)CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1
InChIInChI=1S/C57H113N5O4.2C56H112N4O3.2C53H103N5O6/c1-6-11-16-20-24-28-32-41-58(45-37-38-57(65)66-54-36-15-10-5)46-39-55(63)61-50-52-62(53-51-61)56(64)40-47-60(44-35-31-27-23-19-14-9-4)49-48-59(42-33-29-25-21-17-12-7-2)43-34-30-26-22-18-13-8-3;1-6-11-16-20-24-28-33-42-57(46-37-52-63-56(62)38-32-15-10-5)47-39-54-40-48-60(49-41-54)55(61)53-59(45-36-31-27-23-19-14-9-4)51-50-58(43-34-29-25-21-17-12-7-2)44-35-30-26-22-18-13-8-3;1-6-11-16-21-26-31-36-43-57(44-37-32-27-22-17-12-7-2)50-51-59(47-40-35-30-25-20-15-10-5)52-55(61)60-48-41-54(42-49-60)63-56(62)53-58(45-38-33-28-23-18-13-8-3)46-39-34-29-24-19-14-9-4;1-6-11-16-19-22-25-28-35-54(38-31-33-52(61)63-46-14-9-4)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(36-29-26-23-20-17-12-7-2)39-32-34-53(62)64-47-15-10-5;1-6-11-16-19-22-25-28-35-54(36-29-26-23-20-17-12-7-2)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(38-31-33-52(61)63-46-14-9-4)39-32-34-53(62)64-47-15-10-5/h6-54H2,1-5H3;2*54H,6-53H2,1-5H3;2*6-49H2,1-5H3
InChIKeyRMVGBSQZDDITBA-UHFFFAOYSA-N
XLogP66.20
TPSA395.18 Ų
H-Bond Donors
H-Bond Acceptors37
Rotatable Bonds235
Heavy Atoms320
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004524.51
LogP ≤ 566.20
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate?
The IUPAC name of butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate (CID 160670191) is butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate.
What is the SMILES notation for butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate?
The canonical SMILES for butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate is CCCCCCCCCN(CCCC(=O)OCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCCCCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCC(=O)OCCCCC)CCC(=O)N1CCN(C(=O)CCN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCC(OC(=O)CN(CCCCCCCCC)CCCCCCCCC)CC1.CCCCCCCCCN(CCCCCCCCC)CCN(CCCCCCCCC)CC(=O)N1CCN(C(=O)CN(CCCC(=O)OCCCC)CCCC(=O)OCCCC)CC1.CCCCCCCCCN(CCCOC(=O)CCCCC)CCC1CCN(C(=O)CN(CCCCCCCCC)CCN(CCCCCCCCC)CCCCCCCCC)CC1.
What is the InChIKey of butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate?
The InChIKey is RMVGBSQZDDITBA-UHFFFAOYSA-N. The full InChI is InChI=1S/C57H113N5O4.2C56H112N4O3.2C53H103N5O6/c1-6-11-16-20-24-28-32-41-58(45-37-38-57(65)66-54-36-15-10-5)46-39-55(63)61-50-52-62(53-51-61)56(64)40-47-60(44-35-31-27-23-19-14-9-4)49-48-59(42-33-29-25-21-17-12-7-2)43-34-30-26-22-18-13-8-3;1-6-11-16-20-24-28-33-42-57(46-37-52-63-56(62)38-32-15-10-5)47-39-54-40-48-60(49-41-54)55(61)53-59(45-36-31-27-23-19-14-9-4)51-50-58(43-34-29-25-21-17-12-7-2)44-35-30-26-22-18-13-8-3;1-6-11-16-21-26-31-36-43-57(44-37-32-27-22-17-12-7-2)50-51-59(47-40-35-30-25-20-15-10-5)52-55(61)60-48-41-54(42-49-60)63-56(62)53-58(45-38-33-28-23-18-13-8-3)46-39-34-29-24-19-14-9-4;1-6-11-16-19-22-25-28-35-54(38-31-33-52(61)63-46-14-9-4)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(36-29-26-23-20-17-12-7-2)39-32-34-53(62)64-47-15-10-5;1-6-11-16-19-22-25-28-35-54(36-29-26-23-20-17-12-7-2)40-41-56(37-30-27-24-21-18-13-8-3)49-51(60)58-44-42-57(43-45-58)50(59)48-55(38-31-33-52(61)63-46-14-9-4)39-32-34-53(62)64-47-15-10-5/h6-54H2,1-5H3;2*54H,6-53H2,1-5H3;2*6-49H2,1-5H3.
What are the key properties of butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate?
butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate has a molecular weight of 4524.51 g/mol, XLogP of 66.20, 235 rotatable bonds, 0 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for butyl 4-[(4-butoxy-4-oxobutyl)-[2-[4-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]amino]butanoate;butyl 4-[2-[[2-[4-[2-[(4-butoxy-4-oxobutyl)-nonylamino]acetyl]piperazin-1-yl]-2-oxoethyl]-nonylamino]ethyl-nonylamino]butanoate;[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl] 2-[di(nonyl)amino]acetate;3-[2-[1-[2-[2-[di(nonyl)amino]ethyl-nonylamino]acetyl]piperidin-4-yl]ethyl-nonylamino]propyl hexanoate;pentyl 4-[[3-[4-[3-[2-[di(nonyl)amino]ethyl-nonylamino]propanoyl]piperazin-1-yl]-3-oxopropyl]-nonylamino]butanoate is sourced from PubChem (CID 160670191), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).